SB220025
SB220025 is a potent, orally bioavailable, and selective p38 MAPK inhibitor that also suppresses p56Lck and PKC activity. It disrupts endothelial growth hormone-induced calcium signaling and angiogenesis, making it a valuable compound for studying inflammatory diseases such as arthritis in both cellular and animal models.
Product Specifications
CAS Number
165806-53-1
Product Name Alternative
SB 220025, SB220025, SB-220025
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction
Purity
99.44% (May vary between batches)
Solubility
DMSO:100 mg/mL (295.53 mM)
Smiles
FC1=CC=C (C=C1) C=2N=CN (C2C=3N=C (N=CC3) N) C4CCNCC4
Molecular Formula
C18H19FN6
Molecular Weight
338.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-CL-M0201-01 24 Tests
Mouse CD40L -Cluster of Differentiation 40 Ligand- CLIA Kit
Sign In for Pricing
View Details E-CL-M0201-02 48 Tests
Mouse CD40L -Cluster of Differentiation 40 Ligand- CLIA Kit
Sign In for Pricing
View Details E-CL-M0201-03 96 Tests
Mouse CD40L -Cluster of Differentiation 40 Ligand- CLIA Kit
Sign In for Pricing
View Details E-CL-M0201-04 5x 96 Tests
Mouse CD40L -Cluster of Differentiation 40 Ligand- CLIA Kit
Sign In for Pricing
View Details E-CL-M0201-05 10x 96 Tests
Mouse CD40L -Cluster of Differentiation 40 Ligand- CLIA Kit
Sign In for Pricing
View Details 